THE EFFECT OF PLANT EXTRACT ON BIOCHEMICAL CHANGES IN THE BLOOD PLASMA OF HEPATITIS MODEL RATS

Abstract

This experimental study evaluated the hepatoprotective properties of aqueous and alcoholic extracts prepared from cabbage leaves (Brassica L.) in a model of hepatitis induced by carbon tetrachloride (CCl₄). During the study, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin in blood plasma, and malondialdehyde (MDA) in liver homogenate were measured. The results demonstrated the effectiveness of cabbage leaf extracts in reducing liver damage and enhancing antioxidant protection.

Journal of Multidisciplinary Sciences and Innovations
Source type: Journals
Years of coverage from 2022
inLibrary
Google Scholar
 
Branch of knowledge
CC BY f
761-763
0

Downloads

Download data is not yet available.
To share
Kuziev , S., Norkilicheva , S., Zhalilova , C., Yunusova , M., Izzatillaeva , S., Zaynieva , M., & Tazhieva , O. (2025). THE EFFECT OF PLANT EXTRACT ON BIOCHEMICAL CHANGES IN THE BLOOD PLASMA OF HEPATITIS MODEL RATS. Journal of Multidisciplinary Sciences and Innovations, 1(4), 761–763. Retrieved from https://www.inlibrary.uz/index.php/jmsi/article/view/123245
0
Citations
Crossref
Сrossref
Scopus
Scopus
Journal of Multidisciplinary Sciences and Innovations

Abstract

This experimental study evaluated the hepatoprotective properties of aqueous and alcoholic extracts prepared from cabbage leaves (Brassica L.) in a model of hepatitis induced by carbon tetrachloride (CCl₄). During the study, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin in blood plasma, and malondialdehyde (MDA) in liver homogenate were measured. The results demonstrated the effectiveness of cabbage leaf extracts in reducing liver damage and enhancing antioxidant protection.


background image

https://ijmri.de/index.php/jmsi

volume 4, issue 5, 2025

761

THE EFFECT OF PLANT EXTRACT ON BIOCHEMICAL CHANGES IN THE BLOOD

PLASMA OF HEPATITIS MODEL RATS

Tazhieva Oyimjan

Lecturer,

Urgench College of Public Health

named after Abu Ali ibn Sino

ayimjan25@gmail.com

Zaynieva Makhbuba

Master,

National University of Uzbekistan

anvaroripov74@gmail.com

Izzatillaeva Sabina

Master,

National University of Uzbekistan

izzatillayevasabina3@gmail.com

Yunusova Muslima

Acting associate professor of the

National University of Uzbekistan, PhD

muslima8390@gmail.com

Zhalilova Charos

PhD, National University of Uzbekistan

acharos@mail.ru

Norkilicheva Shokhida

Lecturer,

Branch of Kazan (Volga Region)

Federal University in Jizzakh

shoxida1987@mail.ru

Kuziev Sherali

Associate Professor of the

National University of Uzbekistan, PhD

kuziev.sherali@gmail.com

Abstract:

This experimental study evaluated the hepatoprotective properties of aqueous and

alcoholic extracts prepared from cabbage leaves (Brassica L.) in a model of hepatitis induced by

carbon tetrachloride (CCl₄). During the study, the levels of alanine aminotransferase (ALT),

aspartate aminotransferase (AST), alkaline phosphatase (ALP), albumin in blood plasma, and

malondialdehyde (MDA) in liver homogenate were measured. The results demonstrated the

effectiveness of cabbage leaf extracts in reducing liver damage and enhancing antioxidant

protection.

Keywords:

Brassica L.

, hepatoprotection, carbon tetrachloride, antioxidant, ALT, AST, MDA

Introduction.

Hepatitis is a disease characterized by inflammation of liver tissue and can be

caused by viruses, toxic substances (such as carbon tetrachloride), pharmaceutical agents, or

autoimmune factors. Toxic forms of hepatitis are studied using experimental models to evaluate

the efficacy of novel protective agents. Carbon tetrachloride (CCl₄) is widely used for modeling


background image

https://ijmri.de/index.php/jmsi

volume 4, issue 5, 2025

762

toxic hepatitis, as it enhances lipid peroxidation by generating free radicals in liver cells and

causes damage to cellular membranes [7].

In recent years, plant-based preparations have attracted significant interest as hepatoprotective

agents. The cabbage plant (Brassica L.), belonging to the Brassica genus, contains bioactive

compounds with antioxidant, anti-inflammatory, and cytoprotective properties [1, 2].

Materials and Methods

The experimental animals were divided into five groups:

1.

Healthy Control (HC) – no substances were administered.

2.

Hepatitis Model (HM) – only CCl₄ was administered.

3.

HM + Aqueous Extract – hepatitis model + aqueous extract of cabbage leaves (30 mg/kg,

orally).

4.

HM + Alcoholic Extract – hepatitis model + alcoholic extract of cabbage leaves (30

mg/kg, orally).

5.

HM + Karsil – hepatitis model + standard hepatoprotector Karsil (30 mg/kg, orally) [5].

Biochemical analysis.

After a 10-day experiment, the levels of ALT (alanine aminotransferase)

and AST (aspartate aminotransferase) were evaluated in the blood samples of the animals [6].

Results

ALT and AST enzymes are key intracellular liver enzymes, and their elevation in plasma

indicates damage to hepatic parenchymal cells. ALT, in particular, has high specificity for liver

tissue. In healthy rats, the ALT and AST levels remained within physiological limits, measuring

16.7 and 31.3 U/L, respectively. This indicates intact liver cell membranes and good functional

status. In the model group administered carbon tetrachloride (CCl₄), ALT and AST levels were

significantly elevated (ALT – 40.6; AST – 65.4 U/L), suggesting that CCl₄ damaged hepatocyte

membranes, leading to the leakage of these enzymes into the bloodstream. This increase is

associated with enhanced lipid peroxidation and hepatocellular necrosis caused by CCl₄. Similar

findings were reported by Ilbey et al. (2019), who observed a 2–3-fold increase in ALT and AST

levels in CCl₄-treated rats [3].

In rats treated with the aqueous plant extract, ALT and AST levels decreased compared to the

hepatitis model group (ALT – 22.5; AST – 36.7 U/L), indicating a partial hepatoprotective effect

of the extract. Polyphenols and flavonoids present in the plant may have mitigated liver damage

by neutralizing free radicals. In the group receiving the alcoholic extract, ALT and AST levels

were 27.4 and 40.2 U/L, respectively, which suggests the aqueous extract was relatively more

effective. This may be due to more efficient extraction of bioactive compounds in water.

Glucosinolates and flavonoids are particularly more extractable in aqueous media. Kwon et al.

(2014) demonstrated the hepatoprotective effect of cabbage extract against CCl₄-induced liver

injury and confirmed its efficacy in reducing enzyme levels [4].

In the group treated with the standard hepatoprotector Karsil, ALT and AST levels were the

lowest (ALT – 21.4; AST – 34.5 U/L), reaffirming the drug's high efficacy. However, the fact

that the aqueous extract showed comparable results indicates that cabbage extract may have

potential as a hepatoprotective agent. The dynamics of ALT and AST enzymes confirm that the

CCl₄-induced liver injury model was successfully established.


background image

https://ijmri.de/index.php/jmsi

volume 4, issue 5, 2025

763

The activity levels of alanine aminotransferase (ALT) and aspartate aminotransferase

(AST) enzymes in rat blood serum (M±m, n=5)

The aqueous extract of cabbage (Brassica L.), in particular, demonstrated hepatoprotective

properties by restoring the levels of liver enzymes to values close to those in the control group.

These findings suggest that cabbage extract may be a potential protective agent in the treatment

of hepatitis.

Conclusion.

Experimental studies have demonstrated that both aqueous and alcoholic extracts of

cabbage (Brassica L.) leaves have a positive effect on liver function in a hepatitis model. In rats

with induced hepatitis, levels of ALT (40.6 U/L) and AST (65.4 U/L) were significantly elevated

compared to healthy animals, indicating serious hepatic dysfunction. The administration of

cabbage extracts significantly normalized these biochemical indicators, supporting their potential

as effective hepatoprotective agents.

References:

1. Fahey J. W., Zhang Y., Talalay P. Broccoli sprouts: An exceptionally rich source of inducers

of enzymes that protect against chemical carcinogens//Proc. Natl. Acad. Sci. USA. – 1997. – Vol.

94. – P. 10367–10372.

2. Herr I., Büchler M. W. Dietary constituents of broccoli and other cruciferous vegetables:

Implications for prevention and therapy of cancer//Cancer Treat. Rev. – 2010. – Vol. 36(5). – P.

377–383.

3. Ilbey B., Ozmen O., Orun I. et al. Hepatoprotective effect of plant-derived antioxidants in

experimental liver injury models // Journal of Ethnopharmacology. – 2019. – Vol. 236. – P. 172–

181.

4. Kwon D. J., Bae Y. S., Ju S. M. et al. Anti-inflammatory effects of sulforaphane on hepatic

damage in a murine model//International Immunopharmacology. – 2014. – Vol. 18(2). – P. 276–

282.

5. Singh A., Bhat T. K., Sharma O. P. Clinical biochemistry of hepatotoxicity//Journal of

Clinical Toxicology. – 2011. – Vol. S4. – P. 001.

6. Исаева А. И., Киселева Т. Л. Лекарственные растения с гепатопротекторной

активностью//Фармакогнозия. – М.: ГЭОТАР-Медиа, 2019. – С. 179–185.

7. Климова И. Д., Громова О. А. Антиоксиданты и печеночная патология: современное

представление//Вестник восстановительной медицины. – 2020. – № 2. – С. 43–47.

References

Fahey J. W., Zhang Y., Talalay P. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens//Proc. Natl. Acad. Sci. USA. – 1997. – Vol. 94. – P. 10367–10372.

Herr I., Büchler M. W. Dietary constituents of broccoli and other cruciferous vegetables: Implications for prevention and therapy of cancer//Cancer Treat. Rev. – 2010. – Vol. 36(5). – P. 377–383.

Ilbey B., Ozmen O., Orun I. et al. Hepatoprotective effect of plant-derived antioxidants in experimental liver injury models // Journal of Ethnopharmacology. – 2019. – Vol. 236. – P. 172–181.

Kwon D. J., Bae Y. S., Ju S. M. et al. Anti-inflammatory effects of sulforaphane on hepatic damage in a murine model//International Immunopharmacology. – 2014. – Vol. 18(2). – P. 276–282.

Singh A., Bhat T. K., Sharma O. P. Clinical biochemistry of hepatotoxicity//Journal of Clinical Toxicology. – 2011. – Vol. S4. – P. 001.

Исаева А. И., Киселева Т. Л. Лекарственные растения с гепатопротекторной активностью//Фармакогнозия. – М.: ГЭОТАР-Медиа, 2019. – С. 179–185.

Климова И. Д., Громова О. А. Антиоксиданты и печеночная патология: современное представление//Вестник восстановительной медицины. – 2020. – № 2. – С. 43–47.